Search - tctmd.com

Displaying 801 - 820 of 1581

Sort: Relevancy | Date

Study Affirms Thrombotic Risk in COVID-19

News Daily News

Study Affirms Thrombotic Risk in COVID-19

October 01, 2020

COVID-19: TCTMD’s Daily Dispatch for October

News Daily News

COVID-19: TCTMD’s Daily Dispatch for October

October 01, 2020

TCTMD’s Top 10 Most Popular Stories for September 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

October 01, 2020

ECMO Registry Data Show Progress in COVID-19

News Daily News

ECMO Registry Data Show Progress in COVID-19

October 01, 2020

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

News Daily News

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

September 30, 2020

Young Women With AMICS: High Risk, Inadequate Care

News Daily News

Young Women With AMICS: High Risk, Inadequate Care

September 29, 2020

Aspirin Alone After TAVR Supported by Meta-analysis

News Daily News

Aspirin Alone After TAVR Supported by Meta-analysis

September 29, 2020

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin

News Daily News

ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin

September 21, 2020

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

Pesco-Mediterranean Diet Should Be the Gold Standard, Says JACC Review

News Daily News

Pesco-Mediterranean Diet Should Be the Gold Standard, Says JACC Review

September 15, 2020

Renal Function Gains Seen in CKD Patients After TAVR

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

September 15, 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

COVID-19: TCTMD’s Daily Dispatch for September

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September

September 01, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

August 31, 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

News Conference News ESC 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

August 31, 2020

Trimetazidine Safe but Not Protective Long-term After PCI

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

August 30, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.